Holding website  

  • About Us
    • What we do
      • Strategic Approach
    • Management Team
    • Collaboration & Partnering
    • Investors
    • Careers
      • Open Positions
        • Head of Medical Affairs
    • Privacy
  • APR Products
    • Prescription Healthcare Products
      • PKU GOLIKE® Family
      • Nexodyn® – Advanced Wound Care
        • Tehclo Technology
      • Diclofenac Immediate Release
        • Immediate Release Technology
        • Diclofenac 50 mg products
      • Ondansetron ODF
        • ODF Technology
        • Ondansetron ODF products
      • APR TD011 – Epidermolysis Bullosa
        • Tehclo Technology
      • APR TD012 – Hailey Hailey Disease
        • Tehclo Technology
      • APR 1204 – Ocular Surface Diseases
        • Tehclo Technology
      • Exelya®
        • Exelya®
        • Tehclo Technology
    • Consumer Healthcare Products
      • Acute Pain
        • Diclofenac 25 mg products
      • Healthy Aging – SwitzAge™
      • Pediatric
        • Halykoo
    • Therapeutical Areas
      • Inherited Metabolic Disorders
        • What is PKU (Phenylketonuria)?
      • Advanced Wound Care
        • Unmet Medical Need
      • Cancer Supportive Care
        • Nausea and vomiting
        • Oncodermatology
      • CNS (migraine)
      • Rare Dermatological Diseases
        • Epidermolysis Bullosa
        • Hailey Hailey Disease
      • Eye laser surgery
    • Pipeline
  • Our Services
    • Solid Dosage Forms
      • Oral Pharmaceuticals
        • Integrated project development
        • Project design planning
      • Oral Nutraceuticals
        • Integrated project development
        • Project design planning
      • Oral Medical Devices
        • Integrated project development
        • Project design planning
    • Non-Solid Dosage Forms
      • Topical Pharmaceuticals
        • Integrated project development
        • Project design planning
      • Topical Dermocosmetics
        • Integrated project development
        • Project design planning
      • Topical Medical Devices
        • Integrated project development
        • Project design planning
    • Analytical Services
    • Certifications
  • Media
    • Presentations
    • Press Releases
  • Contacts
    • Location
    • Vigilance
    • APR LAB

Discover who we are and our partners global network, as well as learn more about our people.

Learn more about our products and how they provide innovative solutions for patiens' unmet needs.

Discover our capabilities in project design services.

Find information such as website news, press releases and event presentations.

Get in touch with us to set up a meeting or propose your cooperation.

 

Holding website  

  • About Us
    • What we do
      • Strategic Approach
    • Management Team
    • Collaboration & Partnering
    • Investors
    • Careers
      • Open Positions
        • Head of Medical Affairs
    • Privacy
  • APR Products
    • Prescription Healthcare Products
      • PKU GOLIKE® Family
      • Nexodyn® – Advanced Wound Care
        • Tehclo Technology
      • Diclofenac Immediate Release
        • Immediate Release Technology
        • Diclofenac 50 mg products
      • Ondansetron ODF
        • ODF Technology
        • Ondansetron ODF products
      • APR TD011 – Epidermolysis Bullosa
        • Tehclo Technology
      • APR TD012 – Hailey Hailey Disease
        • Tehclo Technology
      • APR 1204 – Ocular Surface Diseases
        • Tehclo Technology
      • Exelya®
        • Exelya®
        • Tehclo Technology
    • Consumer Healthcare Products
      • Acute Pain
        • Diclofenac 25 mg products
      • Healthy Aging – SwitzAge™
      • Pediatric
        • Halykoo
    • Therapeutical Areas
      • Inherited Metabolic Disorders
        • What is PKU (Phenylketonuria)?
      • Advanced Wound Care
        • Unmet Medical Need
      • Cancer Supportive Care
        • Nausea and vomiting
        • Oncodermatology
      • CNS (migraine)
      • Rare Dermatological Diseases
        • Epidermolysis Bullosa
        • Hailey Hailey Disease
      • Eye laser surgery
    • Pipeline
  • Our Services
    • Solid Dosage Forms
      • Oral Pharmaceuticals
        • Integrated project development
        • Project design planning
      • Oral Nutraceuticals
        • Integrated project development
        • Project design planning
      • Oral Medical Devices
        • Integrated project development
        • Project design planning
    • Non-Solid Dosage Forms
      • Topical Pharmaceuticals
        • Integrated project development
        • Project design planning
      • Topical Dermocosmetics
        • Integrated project development
        • Project design planning
      • Topical Medical Devices
        • Integrated project development
        • Project design planning
    • Analytical Services
    • Certifications
  • Media
    • Presentations
    • Press Releases
  • Contacts
    • Location
    • Vigilance
    • APR LAB
  

PKU GOLIKE Plus:
Phe-free amino acid mix for PKU

PKU GOLIKE is a food for special medical purposes for the dietary management of Phenylketonuria (PKU).
It consists in a Phe-free amino acid mix, that comes in boxes with 30 practical sachets.
Each sachet contains the unflavoured formulation in granules with 15 g or 20 g of Protein Equivalents (P.E.) vitamins and minerals.
PKU GOLIKE Plus
Engineered with the patented Phyisiomimic Technology™, PKU GOLIKE Plus' coated granules allow a prolonged release of amino acids and their physiological absorption, also masking unpleasant odour and taste, and preventing aftertaste.1,2

PKU GOLIKE: FEEL A WIDER RANGE OF OPPORTUNITIES

PKU GOLIKE Plus in granules is versatile and can be consumed in different ways according to patients’ preferences. It can be taken on its own, mixed with creamy food or thick drinks or with GOLIKE Shake & Drink.
PKU GOLIKE Plus is unflavoured thanks to its formulation in coated granules which is able to mask the typical unpleased taste of AA, thus allowing to perceive the original taste of food, maintaining it unaltered when the granules are mixed in.

SOME TIPS ON HOW TO USE PKU GOLIKE GRANULES

One of the many options to take PKU GOLIKE Plus is by mixing the granules with creamy food and thick drinks at the end of each preparation.
Protein substitutes within foods could sound weird, especially at the beginning and getting used to it can take time, but the key is to be persistent and remember that granules grant the benefits!
Here’s a list of quick DO’S & DON’TS to integrate PKU GOLIKE granules into your daily life!
how to use PKU GOLIKE
And if you are looking for some ideas, get inspired by these video recipes with PKU GOLIKE and try it with all your dishes from main courses to desserts!
PKU GOLIKE pumpkin potato soup

Pumpkin and potato soup

PKU GOLIKE jack burger

Jack Burger

PKU GOLIKE mediterranean roast vegetables

Mediterranean roast vegetables

PKU GOLIKE fruity smoothie

Fruity Smoothie

PKU GOLIKE mini cheesecake

Mini Cheese Cake

And it’s not over!
For those who prefer to drink their amino acid mix, PKU GOLIKE granules can be sipped in combination with GOLIKE Shake & Drink, a slightly gelled water-based solution, that suspends the granules making the intake as easy as drinking a glass of water.
GOLIKE Shake&Drink
Nutritional information


The bottle of GOLIKE Shake & Drink is unflavored, but if you prefer something tastier now you can flavour it before adding the PKU GOLIKE granules!!
How?

With GOLIKE Flavouring kit!



Choose your favourite taste among Forest fruits or Exotic fruits to turn the water-jelled solution into your personal drink, then add the granules and take your amino acid mix in just a few sips!
GOLIKE Flavouring Kit
Nutritional information


Choose the flavour with GOLIKE Flavouring kit! Discover more here!



Please refer to your doctor or your medical centre to discuss daily doses, depending on age, bodyweight, medical condition and any special conditions (e.g. pregnancy and breastfeeding).

PKU GOLIKE Plus must be used under medical supervision.
References:
  1. Scheinin M, et al. Amino acid plasma profiles from a prolonged-release protein substitute for phenylketonuria: a randomised, single-dose, four-way crossover trial in healthy volunteers. Nutrients. 2020;12(6):1653.
  2. Giarratana N et al. A New Phe-Free Protein Substitute Engineered to Allow a Physiological Absorption of Free Amino Acids for Phenylketonuria. 2018. Journal of Inborn Errors of Metabolism & Screening.
APR 2015 all rights reserved | About us | APR Products | Our services | News & Events | Contact | Privacy policy | Cookie policy | Sitemap